|
Index of reports
> Cases with Alanine Aminotransferase Increased ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vesicare (Solifenacin) where reactions include alanine aminotransferase increased. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Vesicare side effects in female
Reported by a physician from Japan on 2012-07-24
Patient: female, weighing 61.5 kg (135.3 pounds)
Reactions: Blood Alkaline Phosphatase Increased, Hepatic Function Abnormal, Autoimmune Hepatitis, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Condition Aggravated, Gamma-Glutamyltransferase Increased, Aspartate Aminotransferase Increased
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Vesicare
Other drugs received by patient: Urso 250; Lactoferrin; Visrrat; Urso 250; Saliveht Teijin; Ibruprofen
Possible Vesicare side effects in 73 year old male
Reported by a consumer/non-health professional from Japan on 2011-12-26
Patient: 73 year old male, weighing 51.0 kg (112.2 pounds)
Reactions: Liver Injury, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Hepatic Function Abnormal, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, False Positive Investigation Result, Drug Interaction, Aspartate Aminotransferase Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Saxagliptin
Dosage: saxagliptin tablet patient was withdrawn from the study on 22apr2011
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2010-11-12
End date: 2011-04-21
Sennoside
Dosage: sennoside tablet,1df=36-72mg
Administration route: Oral
Indication: Constipation
Start date: 2010-12-10
Vesicare
Dosage: vesicare tablet 03aug09-15aug11:743days 19aug2011-22aug2011(4 dys)
Administration route: Oral
Indication: Hypertonic Bladder
Start date: 2009-08-03
End date: 2011-08-22
Flivas
Dosage: flivas tablet,31aug09-26sep10(50mg),27sep10-15aug11:323days(75mg);19aug2011-25sep11(38d)
Administration route: Oral
Indication: Benign Prostatic Hyperplasia
Start date: 2010-09-27
End date: 2011-09-25
Glufast
Dosage: glufast tablet
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2008-05-30
End date: 2011-09-13
Other drugs received by patient: Pursennid; Petrolatum; Kary UNI
Possible Vesicare side effects in 55 year old female
Reported by a pharmacist from Japan on 2011-12-23
Patient: 55 year old female
Reactions: Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased
Drug(s) suspected as cause:
Vesicare
|
